Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages

Bibliographic Details
Title: Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
Authors: Yan Cheng, Fumou Sun, Daisy V. Alapat, Visanu Wanchai, David Mery, Eric R. Siegel, Hongwei Xu, Sarah Johnson, Wancheng Guo, Clyde Bailey, Cody Ashby, Michael Anton Bauer, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D. Shaughnessy, Fenghuang Zhan
Source: Blood Cancer Journal, Vol 14, Iss 1, Pp 1-12 (2024)
Publisher Information: Nature Publishing Group, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Tumor immune microenvironmental alterations occur early in multiple myeloma (MM) development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages, i.e., monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), to newly diagnosed MM, comparing these to healthy donors. Using CIBERSORT, mass cytometry (CyTOF), and single-cell RNA sequencing (scRNA-Seq), we examined innate and adaptive immune changes across these stages. We found a decrease in granulocytes in the TME predicts MM outcomes. HLA-DR is reduced in CD16+ monocytes and plasmacytoid dendritic cells, while myeloid dendritic cells show decreased expression of stress and immune-response genes. NK cells and CD8+ T cells shift from a GZMK+ to a GZMB+ cytotoxic phenotype in the TME, with increased inhibitory markers TIM3 and TIGIT. In paired samples, the proportion and gene expression pattern in patient-specific GZMB+CD8+ T cells remain largely unchanged despite MM progression. Our findings provide a comprehensive immune landscape of MM and its precursors, offering insights into therapeutic strategies. Enhancing neutrophil and NK cell cytotoxicity, tumor antigen presentation, and CD8+ T cell versatility in precursor stages may prevent MM progression.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2044-5385
Relation: https://doaj.org/toc/2044-5385
DOI: 10.1038/s41408-024-01172-x
Access URL: https://doaj.org/article/e8dd857feedf48c5930d5a49c2504046
Accession Number: edsdoj.8dd857feedf48c5930d5a49c2504046
Database: Directory of Open Access Journals
More Details
ISSN:20445385
DOI:10.1038/s41408-024-01172-x
Published in:Blood Cancer Journal
Language:English